Biomarkers of neurodegenerative diseases

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 3, 2011, Pages 343-344

  Herrmann, Wolfgang ^a   Obeid, Rima ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; BETA SECRETASE INHIBITOR; BIOLOGICAL MARKER; GAMMA SECRETASE INHIBITOR; TAU PROTEIN;

ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; DEGENERATIVE DISEASE; DEMENTIA; DIABETES MELLITUS; EDITORIAL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; MILD COGNITIVE IMPAIRMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; SMOKING; STROKE;

BIOLOGICAL MARKERS; HUMANS; NEURODEGENERATIVE DISEASES;

EID: 79952789641     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.089     Document Type: Editorial

References (5)

1. Wimo A, Prince M. Alzheimer's disease. International: World Alzheimer Report 2010. The Global Economic Impact of Demenlia.
2. Lewczuk P, Kamrowski-Kruck H, Peters O, Heuser I, Jessen F, Popp J, et al. Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: A multicenter study. Mol Psychiatry 2010;15:138-45.
3. Olsson A, Hoglund K, Sjogren M, Andreasen N, Minthon L, Lannfelt L, et al. Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients. Exp Neurol 2003;183:74-80. (Pubitemid 37075858)
4. Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. J Am Med Assoc 2009;302:385-93.
5. Schupf N, Tang MX, Fukuyama H, Manly J, Andrews H, Mehta P, et al. Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease. Proc Natl Acad Sci USA 2008;105:14052-7.